RxSight, Inc (RXST) insider trading
Every open-market stock purchase and sale by RxSight, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Mark Wilterding (CFO) and 3 others sold $118K in the last 90 days.
- Last insider buy: Jesse Anderson Corley (Insider), $55K, 21 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $118K (4 sales). Last close $5.08 on Oct 22, 2026.
Recent RXST insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | Eric Weinberg (Insider) | Bought (not open market) | — |
| Sep 5, 2026 | Ronald M Kurtz MD (C-suite exec) | Sold (not open market) | $8.4M |
| Sep 5, 2026 | Ronald M Kurtz MD (C-suite exec) | Sold (not open market) | $6.1M |
| Sep 5, 2026 | Ronald M Kurtz MD (C-suite exec) | Sold (not open market) | $5.4M |
| Sep 5, 2026 | Eric Weinberg (Insider) | Sold (not open market) | $5.2M |
| Sep 5, 2026 | Ilya Goldshleger (COO) | Sold (not open market) | $5.2M |
| Sep 5, 2026 | Eric Weinberg (Insider) | Sold (not open market) | $3.5M |
| Sep 5, 2026 | Ilya Goldshleger (COO) | Sold (not open market) | $3.5M |
| Sep 5, 2026 | Ronald M Kurtz MD (C-suite exec) | Sold (not open market) | $3M |
| Sep 5, 2026 | Mark Wilterding (CFO) | Sold (not open market) | $2.6M |
| Sep 5, 2026 | Eric Weinberg (Insider) | Sold (not open market) | $2.3M |
| Sep 5, 2026 | Ilya Goldshleger (COO) | Sold (not open market) | $2.3M |
| Sep 5, 2026 | Ilya Goldshleger (COO) | Sold (not open market) | $1.8M |
| Sep 5, 2026 | Mark Wilterding (CFO) | Bought (not open market) | $1.6M |
| Sep 5, 2026 | Ronald M Kurtz MD (C-suite exec) | Bought (not open market) | $1.6M |
| Sep 5, 2026 | Ilya Goldshleger (COO) | Sold (not open market) | $1.6M |
| Sep 5, 2026 | Eric Weinberg (Insider) | Sold (not open market) | $1.4M |
| Sep 5, 2026 | Eric Weinberg (Insider) | Sold (not open market) | $1.4M |
| Sep 5, 2026 | Ronald M Kurtz MD (C-suite exec) | Bought (not open market) | $1.1M |
| Sep 5, 2026 | Ronald M Kurtz MD (C-suite exec) | Bought (not open market) | $1M |
| Sep 5, 2026 | Ilya Goldshleger (COO) | Bought (not open market) | $665K |
| Sep 5, 2026 | Ronald M Kurtz MD (C-suite exec) | Bought (not open market) | $613K |
| Sep 5, 2026 | Ilya Goldshleger (COO) | Bought (not open market) | $599K |
| Sep 5, 2026 | Eric Weinberg (Insider) | Bought (not open market) | $599K |
| Sep 5, 2026 | Eric Weinberg (Insider) | Bought (not open market) | $527K |
Who's trading RXST
- Eric Weinberg, Insider: sold $14.2K (1 sale), last Sep 15, 2026
- Ronald M Kurtz MD, C-suite exec: sold $35.5K (1 sale), last Sep 5, 2026
- Mark Wilterding, CFO: sold $54K (1 sale), last Sep 5, 2026
- Ilya Goldshleger, Insider: sold $14.2K (1 sale), last Sep 5, 2026
- Aziz Mottiwala, CEO: other filings, last Jul 24, 2026
- Julie Andrews, Insider: other filings, last Jun 17, 2026
- Robert J Palmisano, Insider: other filings, last Jun 17, 2026
- Bakker Juliet Tammenoms, Insider: other filings, last Jun 17, 2026
- Robert Keith Warner, Insider: other filings, last Jun 17, 2026
- Shweta Maniar, Insider: other filings, last Jun 17, 2026
- Raymond W Cohen, Insider: other filings, last Jun 17, 2026
- Jesse Anderson Corley, Insider: other filings, last Jun 17, 2026
- Tamara Fountain, Insider: other filings, last Jun 17, 2026
- William J Link Phd, Insider: other filings, last Jun 17, 2026
- Scott Gaines, C-suite exec: other filings, last Feb 28, 2026
Get free alerts when an insider at RxSight, Inc files a new trade →